TickerFactsScreenerDevelopers

Syndax Pharmaceuticals Inc (SNDX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$21.33M2015: -$20.51M2016: -$43.77M2017: -$61.95M2018: -$75.88M2019: -$57.54M2020: -$71.42M2021: $26.22M2022: -$151.76M2023: -$229.95M2024: -$339.67M2025: -$273.08M-$273.08M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$273.08M+19.6%
2024-$339.67M-47.7%
2023-$229.95M-51.5%
2022-$151.76M-678.8%
2021$26.22M+136.7%
2020-$71.42M-24.1%
2019-$57.54M+24.2%
2018-$75.88M-22.5%
2017-$61.95M-41.6%
2016-$43.77M-113.4%
2015-$20.51M+3.8%
2014-$21.33M—